The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1444
June 9, 2014
View Complete Issue         Table of Contents 2019 
Extended-Release Hydrocodone (Zohydro ER) for Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Extended-Release Hydrocodone (Zohydro ER) for Pain
June 9, 2014 (Issue: 1444)
The FDA has approved an extended-release oral formulation of the opioid agonist hydrocodone (Zohydro ER – Zogenix) for management of pain severe enough to require continuous, long-term therapy and for which alternative treatment options are...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Extended-Release Hydrocodone (Zohydro ER) for Pain
Article code: 1444b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.